| Status | Topic selection |
| Technology type | Medicine |
| Decision | Awaiting decision |
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 18 November 2024 | Following on from advice received from the company, timelines for this appraisal are to be confirmed whilst the company confirm their regulatory filing plans. As this appraisal has been referred NICE will continue to monitor any development and will update interested parties if the situation changes. |
For further information on how we select topics for development, please see our page about topic selection